Document is current

Article History

Received: 15 May 2024

Accepted: 31 January 2025

First Online: 29 July 2025

Declarations

:

: Not applicable.

: Not applicable.

: AKS is a paid scientific advisor to Somai Pharmaceuticals and Evolve, two companies that are producing cannabinoid medicines. Lenus Global is the company through which NS conducts mental health Medico-legal work. This company is not involved in sales of cannabis products. NS does have a financial relationship with this company. Maple Tree is a cannabis consultancy that doesn’t deal with products. MB is a director of the company. He has no employed financial arrangement. Source Bioscience provides NGS (Next Generation Sequencing) services and does not work with cannabis products. None of the companies were involved in the conception or writing of this article.

: NS is a Consultant Psychiatrist and a medicinal cannabis prescriber in Lenus Global and his private practice. SN is a Senior DNA Scientist at Source Bioscience Cambridge, UK. AKS is a scientific advisor to Somai Pharmaceuticals and Evolve. MB serves as a Director at Maple Tree and is a Consultant Neurologist in the company.